Repligen Corporation
RGEN
$125.45
$1.100.89%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 8.73% | 4.88% | 0.33% | -2.91% | -12.95% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 8.73% | 4.88% | 0.33% | -2.91% | -12.95% |
| Cost of Revenue | 4.85% | 0.07% | -2.40% | -7.43% | -6.90% |
| Gross Profit | 12.74% | 9.93% | 3.19% | 1.82% | -18.43% |
| SG&A Expenses | 5.53% | 11.40% | 9.86% | 20.96% | 12.10% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.68% | 4.78% | 2.36% | 2.98% | 0.21% |
| Operating Income | 82.00% | 6.37% | -23.69% | -58.75% | -79.04% |
| Income Before Tax | -152.37% | -154.45% | -147.67% | -87.54% | -81.96% |
| Income Tax Expenses | -98.62% | -98.94% | -107.20% | 205.30% | -16.13% |
| Earnings from Continuing Operations | -245.82% | -197.56% | -171.68% | -108.03% | -92.37% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -245.82% | -197.56% | -171.68% | -108.03% | -92.37% |
| EBIT | 82.00% | 6.37% | -23.69% | -58.75% | -79.04% |
| EBITDA | 30.16% | 7.31% | -5.94% | -24.09% | -47.99% |
| EPS Basic | -245.56% | -196.86% | -171.04% | -108.01% | -92.39% |
| Normalized Basic EPS | 38.36% | -9.60% | -36.27% | -51.90% | -69.06% |
| EPS Diluted | -259.00% | -201.69% | -173.93% | -108.31% | -92.47% |
| Normalized Diluted EPS | 38.62% | -8.92% | -35.53% | -50.89% | -68.34% |
| Average Basic Shares Outstanding | 0.52% | 0.45% | 0.39% | 0.40% | 0.41% |
| Average Diluted Shares Outstanding | -0.26% | -0.48% | -0.72% | -1.39% | -1.14% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |